Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation
This study has been completed.
Instituto Grifols, S.A.
Information provided by:
Grifols Biologicals Inc.
First received: May 7, 2009
Last updated: NA
Last verified: May 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||July 2005|
|Primary Completion Date:||June 2005 (Final data collection date for primary outcome measure)|